AzTrials
AzTrials

Vaping BehaviorsNCT07038317

A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status

A study testing Intervention in people with Vaping Behaviors and Message Exposure, run by University of Hawaii at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to examine if e-cigarette education messages delivered using a source and presentation tailored to one's vaping status influences young adults' vaping behaviors. The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 18 to 24 yearsHealthy volunteers can take part
Conditions the study is for
Vaping Behaviors, Message Exposure, Young Adults
What is being tested?
Intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteUnited States
Study dates
29 Jul 2026to 31 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-24 years old
  • Fluent in English
  • Not currently using tobacco products other than e-cigarettes at the time of enrollment
  • Have a mobile phone to send and receive text messages

Who cannot join

  • Age below 18 or above 24
  • Not being fluent in English
  • Currently using tobacco products other than e-cigarettes
  • Not having a mobile phone

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Hawaii Cancer Center

    Honolulu, Hawaii, 96822

Other trials in United States

About this study

Official title: Identifying and Examining the Effects of Source and Presentation on Responses to Electronic Cigarette Public Education Messages in Young Adult Vapers and Non-vapers

The goal of this study is to examine if e-cigarette education messages delivered using a source and presentation tailored to one's vaping status influences young adults' vaping behaviors. The main questions it aims to answer are:

  1. Does receiving e-cigarette education messages presented using a source (expert or peer) and sidedness (one or two-sided) optimized for the current vaper group influence vaping cessation among young adults who vape daily?
  2. Does receiving e-cigarette education messages presented using a source (expert or peer) and sidedness (one or two-sided) optimized for the non-vaper group influence vaping initiation among young adults who are susceptible to vaping? Participants will be randomly assigned to either the treatment (receiving messages tailored to one's vaping status) or the control (receiving non-tobacco messages) condition and receive SMS three times per week over the course of 6 months. They will complete self-report assessment and show salivary cotinine results for nicotine testing at 4 timepoints.
Being tested
Intervention, Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterventionOther

    Intervention involves e-cigarette education messages tailored to participants' vaping status that will be sent out in SMS via text messaging three times per week over the course of 6 months.

  • ControlOther

    Participants will receive non-tobacco messages (messages about sun safety) three times per week over the course of 6 months.

Study groups in NCT07038317
Study groupRoleWhat they receive
TreatmentExperimentalParticipants in the treatment arm will receive e-cigarette education messages with source and sidedness optimized to one's vaping status.
Receives: Other: Intervention
ControlPlacebo comparatorParticipants in the control arm will receive messages about sun safety.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported vaping

    Past-30-day vaping (yes/no) will be assessed

    Measured: Baseline, six-month

  2. Biochemical confirmation of vaping

    Salivary cotinine for nicotine testing

    Measured: Baseline, one-month, three-month, six-month

Secondary outcomes (5)
  1. Harm perceptions

    Participants will be asked to indicate the extent to which they think vaping nicotine (using e-cigarettes) is… safe, containing flavors that are safe to use, containing dangerous chemical, harmful to health on a scale from 1 (strongly disagree) to 5 (strongly agree).

    Measured: Baseline, one-month, three-month, six-month

  2. Message perceptions

    Participants will be asked to indicate the extent to which they think the message was worth remembering, grabbed their attention, powerful, convincing, meaningful on a scale from 1 (strongly disagree) to 5 (strongly agree).

    Measured: One-month, three-month, six-month

  3. Message liking

    Participants will be asked to indicate the extent to which they liked the message they saw on a scale from 1 (dislike very much) to 5 (like very much).

    Measured: One-month, three-month, six-month

  4. Number of days of past-30-day e-cigarette use

    Participants will be asked to report the number of days in the past 30 days (between 0 to 30) they used an e-cigarette.

    Measured: From enrollment to the end of study at 24 weeks.

  5. E-cigarette accessibility

    Participants will be assessed how they usually purchase e-cigarettes for themselves with categorical response options of…in person, from the Internet, by phone, don't buy their own. This question will only be asked if response indicates participants are between the ages of 18 and 20 AND have used e-cigarettes more than 0 days in the past 30 days.

    Measured: Baseline, one-month, three-month, six-month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2025
  2. Study start29 Jul 2026
  3. Primary completion30 Dec 2027 (estimated)
  4. Study completion31 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07038317
Sponsor's protocol ID
Lee-2025-1 (4R00CA281094)
Status last verified
Oct 2026
First submitted
10 Jun 2025
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified participants dataset will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Intervention in people with Vaping Behaviors and Message Exposure, run by University of Hawaii at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported vaping (time frame: Baseline, six-month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in